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Accepted 29 October 2014A 31-year-old primigravid patient was referredwith suspicion of
ectopic pregnancy. The patient had irregular menstrual cycles and
did not know the exact date of conception. The patient did not feel
abdominal discomfort but had mild vaginal spotting that was
persistent for 5 days. Transvaginal sonography revealed an empty
uterus with no gestational sac. An intact ectopic mass measuring
about 4.5 cm  4 cm  3 cm, however, was located in the right cul-
de-sac and was surrounded by enormous blood vessels (Fig. 1).
The patient's serum b human chorionic gonadotropin (b-HCG)
level was 40,100 mIU/mL. Contact bleeding of the mass was noted
during the beginning of laparoscopy (Fig. 2A). As soon as packed red
blood cells, fresh frozen plasma, and gelatinethrombin matrix (Flo-
seal; Baxter, Hayward, USA) became available, laparoscopic removal
of the ectopic mass was performed. It was difﬁcult to clearly identify
the underlying structure, which was troubled with signiﬁcant
hemorrhaging owing to the deep implantation of trophoblasts.
During the application of Floseal for enhancing coagulation to
the bleeding site, the blood quickly accumulated. Floseal was partly
pushed away from the bleeding sites prior to the attempt of lapa-
roscopic compression with Surgicel (Ethicon, Somerville, USA)
(oxidized regenerated cellulose). After compression for 6 minutes,
hemorrhage tapering was noted. During the repeated application of
Floseal accompanied by additional laparoscopic compression, 1 mg
of recombinant activated factor VII (Novoseven RT; Novo Nordisk,
Gentofte, Denmark) was intravenously administered. The hemor-
rhaging eventually ceased (Fig. 2B). The estimated blood loss was
2000 mL. Follow-up sonography using color Doppler revealed re-
sidual trophoblastic ﬂows (Fig. 3). On postoperative Day 3, the
patient's serum b-HCG level was 4089 mIU/mL. The patient
received 60mgmethotrexate, which was administered through the* Corresponding author. Department of Obstetrics and Gynecology, Kaohsiung
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week later with a serum b-HCG level of 1223 mIU/mL. On post-
operative Day 42, her serum b-HCG level was < 2 mIU/mL, and
sonography showed that residual trophoblastic ﬂows were no
longer present. The patient had an uneventful recovery.
Abdominal pregnancy is rare; it accounts for only 1.3 % of all
ectopic pregnancies [1]. Systemic methotrexate is well known to
have a limited effect for the primary treatment of ectopic cases with
a high serum b-HCG level (> 5000 mIU/ml) or a large lesion.
Intralesional injection of methotrexate has been successfully used
in a patient presenting with an unruptured abdominal wall preg-
nancy [2]. In the case presented above, primary treatment using
either systemic or intralesional injection of methotrexate was not
suitable because of a high serum b-HCG level and a large lesion.
Additionally, the large lesion was surrounded by enormous blood
vessels, which could result in active bleeding when punctured.
Indeed, injections of methotrexate administered through the
uterine cervix, to obtain high local concentrations, have been used
to achieve a complete resolution of diffuse placenta increta [3].
A large cul-de-sac ectopic mass always creates catastrophic
hemorrhaging during either spontaneous rupture or surgical
evacuation [4,5]. It is difﬁcult to clearly identify the active bleeding
sites from embedded vessels during laparoscopic evacuation. The
fear and risk of injury to the rectum and deep vessels usually result
in incomplete laparoscopic evacuation and limit the use of bipolar
electrocauterization or laparoscopic suturing to control the
bleeding.
Floseal can form and stabilize blood clots at the bleeding sites
within several minutes. Floseal has been used during salpingotomy
of tubal ectopic pregnancy for intractable bleeding resistant to
electrocoagulation [6]. Without coincident external compression to
the hemorrhage points, active bleeding can impair the effect of
Floseal. To save time for immediate compression through laparos-
copy, Surgicel should be inserted into the abdominal cavity prior to
the application of Floseal. Novoseven has beenwidely used, with an
alternative dose, in cases of postpartum hemorrhage due to uterine
atony, placenta accreta, or coagulopathy [7,8]. Floseal and Novos-
even help facilitate clot formation from the outside and inside of
the injured vessels.
To the best of our knowledge, this is the ﬁrst report regarding
the successful management of a large cul-de-sac ectopic pregnancyby Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Transvaginal sonography reveals a cul-de-sac ectopic pregnancy surrounded by
enormous blood vessels (arrows).
Fig. 2. (A) Contact bleeding (arrows) of the large cul-de-sac ectopic mass is noted prior
to laparoscopic evacuation. (B) During laparoscopic evacuation of the ectopic mass, the
bleeding ceases after the application of Floseal, Novoseven, and laparoscopic
compression using Surgicel (arrow).
Fig. 3. Sonography using color Doppler reveals residual trophoblastic ﬂows with a
bizarre pattern.
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tion in combination with the use of Floseal, Novo-seven, laparo-
scopic compression using Surgicel, and postoperative methotrexate
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